Blue Earth Diagnostics Announces Agreement with Siemens Healthineers to Share PET Imaging Agent POSLUMA® (Flotufolastat F 18) Clinical Data to Support AI-based Algorithms Development
–Includes data from Phase 3 LIGHTHOUSE trial evaluating POSLUMA in newly diagnosed prostate cancer–MONROE TOWNSHIP, N.J. & OXFORD, England--(BUSINESS WIRE)--Blue ...